Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Metso Outotec publishes its new strategy and financial targets

Metso Outotec Corporation’s stock exchange release on October 28, 2020, at 09:05 a.m. EETMetso Outotec, created through the combination of Metso Minerals and Outotec on June 30, 2020, has published its new strategy focusing on growth and improving profitability. The company aims to become a top-tier supplier of products, technologies and services in the aggregates and minerals industries and a top financial performer. Metso Outotec’s defined purpose is: “enabling sustainable modern life.”    Metso Outotec’s strong foundation for implementing its strategy and achieving its goals is

Ports Group chooses 700 square meters on Kungsgatan in Gothenburg

Ports Group, which is a market-leading company in brand security, has signed a lease with Wallenstam and is moving its headquarters from Mölnlycke to central Gothenburg. In January next year, it is moving into new premises of just over 700 square meters in order to increase its presence and accessibility in the middle of the city.“We are really looking forward to our move to new, modern premises in central Gothenburg. As a company, we protect brands – legally, digitally and technically and thereby create brand security in all areas of our customers’ brands. An attractive address as well as

Enhertu granted Priority Review in the US for the treatment of HER2-positive metastatic gastric cancer

28 October 2020 07:00 GMT Enhertu granted Priority Review in the US for thetreatment of HER2-positive metastatic gastric cancer Only HER2-directed medicine to demonstrate significant improvement in overall survival compared to chemotherapy for previously treated patients in this setting AstraZeneca and Daiichi Sankyo Company, Limited (Daiichi Sankyo)'s Enhertu (trastuzumab deruxtecan) has received acceptance for its supplemental Biologics License Application (sBLA) and has also been granted Priority Review in the US for the treatment of patients with HER2-positive metastatic

Invitation to presentation of Balco’s third quarter report 2020

Växjö, 28 October 2020Balco’s interim report for the third quarter 2020 will be published at 07:30 CET on November 12, 2020. A web-cast telephone conference will be held at 09:00 CET the same day, where CEO and President Kenneth Lundahl and CFO Michael Grindborn will present the results for the third quarter 2020. A possibility will be given to ask questions via the webcast and follow the presentation material live. The webcast, which afterwards also will be available on demand, will be accessible at Balco’s financial website, www.balcogroup.se or via the following link: https://tv.

Adapteo’s release date for the interim report January to September 2020 has been changed and is brought forward to 2 November

Adapteo Plc Press release 28 October 2020 at 8:00 a.m. CET Adapteo, a leading Northern European company for adaptable buildings, will publish its Business Review for January – September 2020 on Monday 2 November at approximately 07.30 CET. A conference call with a presentation for investors, analysts and media will be held at 09.00 CET the same day. The presentation will be held via teleconference and webcast by President & CEO Philip Isell Lind af Hageby and CFO Erik Skånsberg. The session will start with a presentation, followed by a question-and-answer session and will be held in

Forxiga cardiovascular outcomes benefit approved in China

28 October 2020 07:00 GMT Forxiga cardiovascular outcomes benefit approved in China Update to approval includes DECLARE-TIMI 58 Phase III trial that reduced the riskof composite of hospitalisation for heart failure or cardiovascular death in type-2 diabetes   China's National Medical Products Administration (NMPA) has updated the label for AstraZeneca's Forxiga (dapagliflozin) to include data from the DECLARE-TIMI 58 Phase III trial. DECLARE-TIMI 58 

UNION therapeutics appoints Dr. Kim Kjoeller as Chief Executive Officer and further strengthens leadership by appointing Dr. Günter Ditzinger as Chief Technology Officer

·UNION strengthens leadership following expansion of clinical pipeline from one to five later stage clinical candidates during 2020 · Dr. Kim Domela Kjoeller, Executive Vice President Global Research & Development at LEO Pharma A/S, has been appointed as new Chief Executive Officer with effect from January 1, 2021 · Dr. Günter Ditzinger, who holds 30 years of experience from Sanofi, Novartis and most recently as the Chief Technology Officer of Swiss-based Basilea Pharmaceutica, has been appointed as Chief Technology Officer  Hellerup, Denmark, October 28, 2020 – UNION

Interim Report July–September 2020: Record deliveries offset by a weaker market

LKAB has delivered a strong quarter with deliveries at a record high of 7.6 Mt. However, the effect on operating profit is offset by a lower dollar exchange rate, lower prices for highly upgraded iron ore products and increased costs.Net sales for the third quarter amounted to MSEK 9,333 (7,751), an increase of 20 percent compared with the same period last year. Operating profit decreased to MSEK 2,955 (3,128). The effect of high delivery volumes is offset by a lower dollar exchange rate, as well as lower prices for highly upgraded iron ore products and increased costs. The increased costs

Hexagon Interim Report 1 January - 30 September 2020

Third quarter 2020- Net sales decreased by -2 per cent to 939.9 MEUR (956.3). Using fixed exchange ratesand a comparable group structure (organic growth), net sales was unchanged by 0 per cent- Operating earnings (EBIT1) increased by 6 per cent to 250.1 MEUR (235.8)- Earnings before taxes, excluding non-recurring items, amounted to 242.2 MEUR (229.3)- Net earnings, excluding non-recurring items, amounted to 198.6 MEUR (188.0)- Earnings per share, excluding non-recurring items, amounted to 0.53 EUR (0.51)- Operating cash flow increased to 191.2 MEUR (167.5)- The Board of

Clavister Q3 2020: Revenue Growth of 39%, EBITDA Margin of 22%

October 28, 2020, Örnsköldsvik, Sweden. Clavister, a leader in high-performance cybersecurity solutions, released its third quarterly 2020 interim report today.  "Our third quarter of 2020 saw strong revenue growth of 39 %, record gross margin and an EBITDA margin of 22 %. I am really proud of the Clavister team and partners whom have remained fully operational and focused on delivering solutions to our customers despite the challenges due to the Covid-19 pandemic. The year to date results strengthen our confidence in delivering on our 2020 financial ambition of year-on-year improvements

Finnair Group Interim Report 1 January – 30 September 2020

Finnair Plc        Interim Report      28 October 2020 at 9.00 a.m. EET Heavy COVID-19 impact continued – Finnair implemented further cost reductions and took measures to improve the equity and cash position in line with its rebuild plan. July–September 2020 · Earnings per share were -0.15 euros (0.08)*. · Revenue decreased by 88.7% to 97.4 million euros (865.4). · The comparable operating result was -167.0 million euros (100.7). The operating result was -183.1 million euros (94.9). · Financial net expenses were 74.6 million euros (20.1) and they increased significantly,

Reminder: Invitation to presentation of Orkla’s third quarter 2020 results, Thursday 29 October

Orkla will report its third quarter 2020 results on Thursday, 29 October 2020 at 7.00 a.m. CET.The quarterly report and the presentation material will be available at this time at: https://investors.orkla.com.The results will be presented in a webcast with Presidet & CEO Jaan Ivar Semlitsch and CFO Harald Ullevoldsæter at 8.00 a.m. CET. As a consequence of the Corona situation, there will not be a physical presentation of the results.The presentation and subsequent Q&A session will be held in English and may be viewed live at https://investors.orkla.com (direct link: https://events.

Finnair increases its savings target to 140 million euros of permanent cost base reductions by 2022 onwards, superseding the previously announced target

Finnair Plc         Stock Exchange Release           28 October 2020 at 9.00 a.m. EET On 20 May 2020, Finnair announced that it was targeting nearly 80 million euros in permanent cost base reductions by 2022, compared to 2019 levels.  The company updated the same target in its announcement on 25 August 2020 by increasing it to c. 100 million euros.  Finnair has made good progress in the cost savings programme and has also identified new savings opportunities. As a result, Finnair has increased its savings target by 40 million euros, increasing its previous expectations for a permanent

Amendments to the terms of Finnair pension fund have a positive one-off impact of 85 million euros on Finnair’s Q4 operating result

Finnair Plc         Stock Exchange Release           28 October 2020 at 9.00 a.m. EET Certain amendments to the terms of Finnair pension fund have been approved. The amendments relate to pension index increment removals and are expected to have a positive one-off impact of 85 million euros on Finnair's operating result in Q4 2020. The impact will be reported as an item affecting comparability and, therefore, it has no effect on the comparable operating result. The amendments have no immediate cash flow impact, but the impact is deferred to future years. The amendments form a part of

Interim Report January - September 2020: Relevant, long-term partner

28 October 2020, 8.00 a.m. · Rental income increased by 6 percent to SEK 937.5 million (885.1). · Net operating surplus increased by 10 percent to SEK 753.1 million (681.9). · Profit from property management rose by 13 percent to SEK 542.5 million (478.0). · Profit for the period decreased to SEK 805.1 million (851.8), corresponding to earnings per share of SEK 21.36 (22.59), including changes in value of SEK 475.4 million (583.5). · Net asset value per share, EPRA NAV, increased to SEK 223.34 (194.07). Catena continues to deliver, generating strong cash flows with

Registration for SKF Capital Markets Day 2020 is now open

Gothenburg, 28 October 2020: SKF welcomes institutional investors, financial analysts and financial media to the Group’s first virtual Capital Markets Day on 4 November at 13:00-16:00 (CET). To participate, please register at: https://skf.6connex.com/event/4/register. During the Capital Markets Day, the transformation of the Group into an even stronger SKF will be explained and discussed. This includes transformation of SKF’s manufacturing footprint, operational improvements, new business models and technology investments. As previously announced, the speakers will include Alrik

Stora Enso appoints two new members to its Group Leadership Team

STORA ENSO OYJ STOCK EXCHANGE RELEASE 28 October 2020 at 9.00 EETStora Enso has appointed Tobias Bäärnman, Chief Strategy and Innovation Officer, as a member of the Group Leadership Team. He joined Stora Enso in 2017, first as SVP Controlling, Strategy and IT for Consumer Board division. Since December 2019, he has worked as Chief Strategy and Innovation Officer. Before joining Stora Enso, he worked as Finance Director at Iggesund Paperboard and has earlier held various positions at Statoil and Procter and Gamble. He has a master’s degree in finance. Stora Enso has also appointed Teemu

Neles’ Interim Report January 1 – September 30, 2020

Neles Corporation, Stock exchange release, October 28, 2020 at 09:00 am EETThis is a summary of Neles’ interim review for January 1 - September 30, 2020. The complete report is attached to this release and also available at www.neles.com/results. January-September in brief · Solid adjusted EBITA margin continued in the third quarter despite still challenging Covid-19 pandemic situation, supported by cost saving actions · Pulp and Paper projects continued at a good level; weaker activity in Oil and Gas projects compared to the first half of the year · Increased market activity

Transcom Holding AB (publ): Invitation to Transcom third quarter 2020 results presentation

Transcom are pleased to invite you to their Q3 2020 financial update call on Wednesday, November 11, 2020 at 9:00 CET, following the release of Q3 2020 results at 8:00 am CET. The press release will include a link to the presentation for the call. The materials will also be available on https://www.transcom.com/en/investor-relations. Representing Transcom Jonas Dahlberg, President & CEO Snejana Koleva, CFO   Presentation details Date/Time: Wednesday, November 11, 2020 at 9:00 CET Online Registration link: http://emea.directeventreg.com/registration/9869364 Important

Metso Outotec’s Interim Review January – September 2020

Metso Outotec Corporation’s stock exchange release on October 28, 2020, at 09:00 a.m. EETThe demerger of Metso Corporation and the combination of Metso’s Minerals business and Outotec was completed on June 30, 2020. In the transaction, the legal acquirer Outotec issued new shares to Metso shareholders and received all assets, rights, debts and liabilities related to Metso’s Minerals business. This transaction is treated in IFRS reporting as a reverse acquisition, where Metso Minerals is the accounting acquirer and Outotec the accounting acquiree. The historical IFRS-based information for

MSAB – Solid margins and increased profit

Third Quarter · Net sales came in at 93.3 SEK (93.3) million (+3.4 percent in local currencies). · EBIT amounted to SEK 29.4 (19.9) million. · The EBIT margin was 31.5 (21.3) percent. · Profit after tax amounted to SEK 21.4 (19.1) million. · Earnings per share before/after dilution amounted to SEK 1.16 (1.03). · Cash flow from operating activities amounted to SEK -2.8 (13.5) million. January - September · Net sales increased 8.8 percent to SEK 243.4 (223.7) million (+9.3 percent in local currencies). · EBIT amounted to SEK 32.6 (2.7) million. · The EBIT

Correction in revenues for the Third quarter results 2020: Strong results, increased order backlog

28 October 2020 – In an international market with corona-related volatilities, Kvaerner increased EBITDA -results, order intake and backlog during the third quarter, compared to the same period last year. Simultaneously, the company strengthened its financial platform. A positive cashflow increased the cash and bank deposits to NOK 2 029 million at the end of the quarter.In the last quarter, Kvaerner’s total revenues, including jointly controlled entities (Field Development segment) were NOK 1 836 million, compared to NOK 2 571million  in the third quarter 2019. With a corresponding

Boliden’s third quarter: Improved earnings

Production at Boliden’s mines and smelters remained stable during the quarter. Milled production at the mines, as well as metal production at the smelters, were higher compared to the same period last year. Operating profit, excluding revaluation of process inventory, totaled SEK 2,258 m (1,635).“I am still very proud of the flexibility, stability and commitment that our organization shows. Despite Covid-19, major maintenance stops have been carried out, investments have been put in place, and the production rate in Mines has increased. This at the same time as we have taken comprehensive

Q3 Interim Report 2020

Q3 2020 · Revenues totaled SEK 13,550 m (11,170)  · The operating profit totaled SEK 2,622 m (1,873) · The operating profit, excluding revaluation of process inventory,totaled SEK 2,258 m (1,635) · Free cash flow totaled SEK 1,878 m (-653) · Earnings per share totaled SEK 7.44 (5.14) Improved earnings · Garpenberg and Kevitsa achieve new production rates following completed investments. · The quarter's maintenance shutdowns were successfully completed despite the Covid-19 pandemic. Please find enclosed the full report. The Interim Report will be presented

There are no items matching the current filter
There are no more items matching the current filter
Back to top